Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp81 | Diabetes (1) | ECE2016

Predictive variables of GLP-1 levels in postpartum reassessment of women with previous history of gestational diabetes

Maraver-Selfa Silvia , Jose Picon-Cesar Maria , Munoz-Garach Araceli , Mancha-Doblas Isabel , Tinahones Francisco

Objective: To study the GLP-1 pattern of secretion after an oral glucose tolerance test (OGTT) in women in postpartum reassessment of previous gestational diabetes (GDM). To evaluate clinical and laboratory parameters that can influence GLP-1 secretion.Patients and methods: Forty-eight women with a history of GDM were assessed one year after childbirth determining clinical and analytical characteristics and OGTT with 75 g. We measured glucose, insulin an...

ea0041ep290 | Clinical case reports - Pituitary/Adrenal | ECE2016

Virilizing adrenocortical tumor: a case report

Maraver-Selfa Silvia , Cornejo-Pareja Isabel , Diaz-Perdigones Cristina , Mancha-Doblas Isabel , Tinahones Francisco

Introduction: Adrenal masses are among the most frequent tumours in humans (ACT). A vast majority of these tumours are benign (ACAs). Only a small subset of adrenal masses are malignant adrenocortical carcinomas (ACCs). Tumour size, tumour weight, hormonal function and pathologic criteria are useful clinicopathological criteria that can result in accurate diagnosis of most ACCs and ACAs.Case report: 31-years-old woman, without relevant previous history. ...

ea0041ep481 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Influence of obesity and carbohydrate metabolism disorders in GLP-1 levels in women with history of gestational diabetes mellitus

Maraver-Selfa Silvia , Jose Picon-Cesar Maria , Molina-Vega Maria , Mancha-Doblas Isabel , Tinahones-Madueno Francisco

Introduction: There is a reduction of the incretin effect in patients with type 2 diabetes secondary to altered secretion of incretin hormones and/or failed of its action.Objective: To study the GLP-1 secretion pattern after an oral glucose tolerance test (OGTT) in postpartum reassessment of women with previous GDM.Materials and methods: Prospective epidemiological study of 48 women with a history of GDM. We evaluated age, history ...

ea0056p827 | Pituitary - Clinical | ECE2018

Benefits of pre-surgical treatment with somatostatin analogs in naive patients with acromegaly

Cornejo-Pareja Isabel M , Maraver-Selfa Silvia , Munoz-Garach Araceli , Gonzalez-Molero Inmaculada , Mancha-Doblas Isabel , Tinahones Francisco

Introduction: Somatostatin analogs (SS-analogs) are the treatment option when there is a persistent disease despite surgical intervention. They can be also recommended as a first line treatment if surgery is not appropriate (non-curative or contraindicated surgery).Objetive: To evaluate the effect of first-generation SS-analogs (lanreotide and octreotide) on tumour shrinkage and biochemical control in naive patients.Methods: We per...

ea0063p42 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Endocrine hypertension?

Maraver-Selfa Silvia , Damas-Fuentes Miguel , Cornejo-Pareja Isabel Maria , Molina-Vega Maria , Munoz-Garach Araceli , Hernandez-Garcia Carmen , Mancha-Doblas Isabel , Tinahones Francisco

An 18-years-old woman without medical history was referred for study of hypertension and an adrenal incidentaloma. The family history was significant for essential well-controlled hypertension in her father; diagnosed at 39 years-old. The patient complained of headache, asthenia, edema in lower limbs, high blood pressure values (200/150 mmHg) for one year (well controlled with losartan 100 mg/12 h, amlodipine 10 mg/24 h and doxazosin 4 mg/24 h) and marked facial acne previous ...

ea0063p105 | Calcium and Bone 1 | ECE2019

Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies

Maria Diaz Perdigones Cristina , Maria Gomez Perez Ana , Maria Cornejo Pareja Isabel , Munoz Garach Araceli , Damas Fuentes Miguel , Molina Vega Maria , Maraver Selfa Silvia

Blackground: Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis and treatment because of its rarity, overlapping features with benign parathyroid disease.Case report: 50 years-old-woman, without relevant previous history. She begins to present asthenia, weakness of lower limbs, arthralgias, cramps and appearance of a painfu...

ea0063p717 | Pituitary and Neuroendocrinology 2 | ECE2019

Glycogenosis and hypofisis pathology, importance of a multidisciplinary management

Cornejo-Pareja Isabel , Maraver-Selfa Silvia , Munoz-Garach Araceli , Gonzalo-Marin Montserrat , Hernandez-Garcia Carmen , Damas-Fuentes Miguel , Mancha-Doblas Isabel , Tinahones Francisco J

Introduction: Glycogenosis is a group of hereditary diseases affecting the glycogen metabolism, due to mutations in enzymes involved in the transformation and synthesis of glucose (liver and muscle glycogenosis). Brain germ tumors are very infrequent. They are located mainly in pineal and sellar region. Central diabetes insipidus is the most frequent manifestation. Their prognosis and response to combined chemo/radiotherapy treatment are favorable.Case r...

ea0035p1086 | Thyroid Cancer | ECE2014

Symptomatic hypercalcemia due to primary hyperparathyroidism by parathyroid carcinoma

Cornejo-Pareja Isabel , Gomez-Perez Ana , Maraver-Selfa Silvia , Munoz-Garach Araceli , Molina-Vega Maria , Mancha-Doblas Isabel , Tinahones-Madueno Francisco

Parathyroid carcinoma is a rare cause of primary hyperparathyroidism. Clinical suspicion is determined by the severity of hyperparathyroidism associated or not with palpable cervical tumor and local invasion when surgery.Case report: A 45-year-old woman without any previous history of kidney stones or fractures. Admitted to hospital because of high hypercalcemia (calcium 15.1 mg/dl), fatigue and generalized arthralgia. Physical examination revealed right...

ea0056p507 | Diabetes therapy | ECE2018

Efficacy in metabolic control and weight loss of combined treatment with GLP-1 receptor analogues and SGLT-2 inhibitors

Damas-Fuentes Miguel , Munoz-Garach Araceli , Maraver-Selfa Silvia , Molina-Vega Maria , Hernandez-Garcia Carmen , Diaz-Perdigones Cristina , Tinahones-Madueno Francisco

Introduction: The emergence of a new generation of antidiabetic drugs (GLP-1RA and SGLT-2i) with complementary mechanisms of action offer new alternatives in the treatment of patients with T2D and poor metabolic control.Objectives: To evaluate the efficacy of the aGLP-1 and iSGLT2 combination on metabolic control, weight, blood pressure and insulin dose in patients with DM2.Methods: Observational, retrospective study. We studied T2...

ea0037ep1253 | Clinical Cases–Thyroid/Other | ECE2015

Squamous cell thyroid carcinoma, the importance of early diagnosis and treatment

Cornejo-Pareja Isabel M , Maraver-Selfa Silvia , Garcia-Aleman Jorge , Ortega-Jimenez M Victoria , Munoz-Garach Araceli , Gomez-Perez Ana M , Molina-Vega Maria , Diaz-Perdigones Cristina , Mancha-Doblas Isabel , Tinahones-Madueno Francisco Jose

Introduction: Squamous cell thyroid carcinoma is a very rare malignant epithelial tumour. It presents as rapid growth cervical mass, may affect neighbour structures and sometimes metastasizes other parts of the body. ItÂ’s often associated with previous goiter history and occasionally with autoimmune thyroiditis. It can appear pure, as a component of undifferentiated carcinoma, or combined with differentiated carcinoma areas (papillary or follicular).<p class="abstext"...